Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Chen Shiping, holds the title of Chief Operating Officer at Alamar Biosciences, Inc..
On 2026-04-20, the insider transacted 55,827 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Chen Shiping (Chief Operating Officer) transacted $0 of $ALMR
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.